Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 6-month Interim Analysis of Post-marketing Surveillance.
Takashi YamamuraNoriko IsobeIzumi KawachiChiyoko NoharaYusei MiyazakiMinami TomitaTakahiko TsumurayaKatsuhisa YamashitaJin NakaharaIchiro NakashimaKazuo FujiharaPublished in: Neurology and therapy (2024)
UMIN Clinical Trials Registry, UMIN000041047.